Permanent haloperidol-induced dopamine receptor up-regulation in the ovariectomized rat

https://doi.org/10.1016/0361-9230(91)90094-ZGet rights and content

Abstract

One of the confounding problems associated with the study of tardive dyskinesia in rodent models has been the inability to produce a permanent supersensitivity to dopamine (DA) following neuroleptic drugs. We recently observed that ovariectomy (OVX) results in a permanent dopamine receptor (DA-R) up-regulation in the striatum of the rat. This permanent up-regulation of striatal D2 DA-R required three months to fully develop and lasted for at least 12 months post-OVX. In the present study we further characterized this model by examining the development of both apomorphine-induced stereotypy and D2 DA-R density in the striatum of OVX and Sham-operated rats following haloperidol (16 days at 1.0 mg/kg/day, IP). Following the chronic haloperidol treatment, both the OVX and the Sham-operated animals increased both their behavioral responses (Stereotypic sniffing) to apomorphine, and the density of striatal D2 DA-R. However, by 30 days posthaloperidol, the Sham animals had reverted to normal behavioral responses to apomorphine and normal levels of striatal DA-R, while both the behavioral responses and the density of D2 DA-R in the OVX animals treated with haloperidol remained up-regulated. These data indicate that 1) the time required to develop this unique animal model of a permanent DA-R up-regulation in the ovariectomized (OVX) rat can be considerably shortened; 2) there is probably a unique neurochemical change induced by haloperidol in the OVX but not in Sham rats that leads to the DA-R up-regulation becoming permanent.

References (30)

  • F.J. White et al.

    Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat

    Life Sci.

    (1983)
  • R.J. Baldessarini et al.

    Pathophysiologic basis of tardive dyskinesia

    Adv. Biochem. Psychopharmacol.

    (1980)
  • R.J. Baldessarini

    Drugs and the treatment of psychiatric disorders

  • D.R. Burt et al.

    Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain

    Science

    (1977)
  • A. Carlsson

    Regulation of monoamine metabolism in the central nervous system

  • Cited by (4)

    • Relevance of animal models to human tardive dyskinesia

      2012, Behavioral and Brain Functions
    View full text